About
ABCureD is a multi-awarded health-tech start-up and the first biomedical spin-off of Democritus University of Thrace (DUTH). The company focuses on advancing precision medicine and create value through innovative biomarker discovery and translational research.
By bridging academic excellence with entrepreneurial innovation, ABCureD develops novel diagnostic and therapeutic approaches for complex diseases, with a particular focus on metabolic disorders such as diabetes. LPancreas is our first-in-kind new gen precision diagnosis product, built to transform diabetes care.
What is your business/industry sector?
Healthcare